For: | Usuda D, Kato M, Sugawara Y, Shimizu R, Inami T, Tsuge S, Sakurai R, Kawai K, Matsubara S, Tanaka R, Suzuki M, Shimozawa S, Hotchi Y, Osugi I, Katou R, Ito S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Oba J, Nomura T, Sugita M. Secondary pulmonary infection by Fusarium solani and Aspergillus niger during systemic steroid treatment for COVID-19: A case report. World J Clin Cases 2023; 11(26): 6280-6288 [PMID: 37731582 DOI: 10.12998/wjcc.v11.i26.6280] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v11/i26/6280.htm |
Number | Citing Articles |
1 |
Dulce Andrade-Pavón, Omar Gómez-García, Lourdes Villa-Tanaca. Review and Current Perspectives on DNA Topoisomerase I and II Enzymes of Fungi as Study Models for the Development of New Antifungal Drugs. Journal of Fungi 2024; 10(9): 629 doi: 10.3390/jof10090629
|
2 |
Gladys Beatriz Posse, Fernanda Mariel Barberis, María Fernanda Benedetti, Daniel Pezzola, Katherine Hermida Alava, Carolina Rodríguez Laboccetta, Agustín Videla Garrido, Víctor Fernández Briceño, Paula Capece, Alejandro Nusblat, María Luján Cuestas. COVID-19–associated invasive fungal infections in intensive care unit patients during the first pandemic waves in Argentina: Results of a single center experience. Medical Mycology 2025; 63(3) doi: 10.1093/mmy/myaf024
|
3 |
|